Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON38557Recruiting
Open-label, single-arm trial of aprepitant and fentanyl in cancer pain, sponsored by Erasmus MC. Primary endpoints: AUC and clearance. Started Mar 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON38557.